Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Review of the SWIR Windows to Study Osteoarthritis.

Journal of biophotonics·2026
Same author

Decoherence of photon entanglement by transmission through brain tissue with Alzheimer's disease.

Biomedical optics express·2023
Same author

Photosynthesis on the Ultrafast Time Scale within the Confinements of Quantum Nanostructured Photosystems.

Photochemistry and photobiology·2021
Same author

Majorana vortex photons a form of entangled photons propagation through brain tissue.

Journal of biophotonics·2019

Related Experiment Video

Updated: Mar 15, 2026

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

4.2K

Femtosecond Optical Kerr Effect in Alzheimer's Brain Tissue.

Sandra Mamani1, Laura A Sordillo1, Robert R Alfano1

  • 1Department of Physics, Institute for Ultrafast Spectroscopy and Lasers, The City College of the City University of New York, New York, New York, USA.

Journal of Biophotonics
|March 13, 2026
PubMed
Summary
This summary is machine-generated.

Optical Kerr effect (OKE) spectroscopy reveals higher conductivity in Alzheimer

Keywords:
Alzheimer's diseaseconductivityelectronic mechanismoptical Kerr effectplasma mechanismtime‐resolved spectroscopyultrafast dynamics

More Related Videos

Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases
07:47

Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases

Published on: December 6, 2016

7.6K
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.4K

Related Experiment Videos

Last Updated: Mar 15, 2026

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

4.2K
Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases
07:47

Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases

Published on: December 6, 2016

7.6K
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.4K

Area of Science:

  • Neuroscience
  • Biophysics
  • Spectroscopy

Background:

  • Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline.
  • Understanding the ultrafast dynamics of brain tissue is crucial for diagnosing and treating neurological conditions.
  • Optical Kerr effect (OKE) spectroscopy offers a non-invasive method to probe these dynamics.

Purpose of the Study:

  • To investigate the application of OKE spectroscopy in differentiating between Alzheimer's disease (AD) and normal human brain tissues.
  • To analyze the ultrafast response mechanisms, including electronic and plasma contributions, in brain tissue.
  • To correlate observed conductivity changes with AD-related neuropathological features.

Main Methods:

  • Human brain tissues from hippocampus and Brodmann areas 9 and 17 from both AD and normal subjects were analyzed using OKE spectroscopy.
  • Kerr signals were measured to identify electronic and plasma mechanisms.
  • Plasma relaxation and dielectric response times were calculated to determine conductivity.

Main Results:

  • OKE signals from both AD and normal tissues showed a double-peak profile, indicating electronic and plasma contributions.
  • Hippocampal conductivity in AD tissues was 46%-61% higher than in normal tissues, attributed to increased structural inhomogeneity.
  • Overall mean conductivity was 38% higher in AD tissues across the studied regions.

Conclusions:

  • OKE spectroscopy effectively differentiates AD from normal brain tissue by revealing altered ultrafast dynamics.
  • Increased conductivity in AD brain tissue is linked to structural inhomogeneity, potentially caused by tau and amyloid-beta protein accumulation and higher water content.
  • OKE provides valuable insights into the molecular mechanisms of brain tissue on an ultrafast timescale.